Tilia Fiduciary Partners, Inc. Charles River Laboratories International, Inc. Transaction History
Tilia Fiduciary Partners, Inc.
- $126 Million
- Q2 2024
A detailed history of Tilia Fiduciary Partners, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Tilia Fiduciary Partners, Inc. holds 9,189 shares of CRL stock, worth $1.82 Million. This represents 1.51% of its overall portfolio holdings.
Number of Shares
9,189
Previous 8,526
7.78%
Holding current value
$1.82 Million
Previous $2.31 Million
17.84%
% of portfolio
1.51%
Previous 1.91%
Shares
11 transactions
Others Institutions Holding CRL
# of Institutions
732Shares Held
51.8MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$1.01 Billion0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$414 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$379 Million0.99% of portfolio
-
Clearbridge Investments, LLC New York, NY1.37MShares$272 Million0.24% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.1B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...